The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I result of ICP-192 (gunagratinib), a highly selective irreversible FGFR inhibitor, in patients with advanced solid tumors harboring FGFR pathway alterations.
 
Ye Guo
Research Funding - Hutchison MediPharma; Innovent Biologics, Inc
 
Chunwang Yuan
No Relationships to Disclose
 
Jieer Ying
No Relationships to Disclose
 
Xu Zhu
No Relationships to Disclose
 
Guodong Luan
Employment - Innocare
 
Bin Zhang
Employment - Innocare
 
Renbin Zhao
Employment - Innocare
 
Jin Li
No Relationships to Disclose